Fount of Information

TriLink社 August TriLink Messenger News




                          RESEARCH NEWS





In this blog, we will discuss current and future extraterrestrial activities intended to put a unique CleanTag®-enabled application into a broader context, including astrobiology, the scope of which involves links between life and the universe such as the search for extraterrestrial life, as well as the study of life on earth, its origin, evolution, and limits.


Novel_mRNA.png Encapsulated_mRNA.png


Novel mRNA Vaccine Protects Against Malaria in Mice



Encapsulated mRNA Vaccines ElicitProtective CD8 T Cells


In 2018, there were an estimated 228 million malaria cases and 405,000 deaths worldwide. mRNA vaccines are a promising approach to get the spread of this disease under control, especially following recent successes in tackling COVID-19. Read more about how TriLink's PfCSP mRNA construct has recently helped researchers with important experiments in mice.



In a study soon to publish in Molecular Therapy, Knudson et al. demonstrate that LNP-mRNA vaccines elicit memory CD8 T cells in a mouse model of smallpox to protect from lethal viral challenge. This finding has significance for other LNP-mRNA vaccines, including those against SARS-CoV-2.




                        UPCOMING EVENTS




TriLink is proud sponsor of the upcoming Gen webinar The future of RNA Therapeutics is Modular.


In this webinar, Professor Dan Peer will discuss the state of RNA-based therapeutics, particularly developing a self-assembled modular platform that enables the construction of a theoretically unlimited repertoire of RNA-targeted carriers. He will present a novel approach for delivering modified mRNA to specific cell types in vivo utilizing this platform.


                                    Tuesday, Aug 31, 2021, 9:00 a.m. PDT

                                           (日本時間 9月1日(水) 午前1時)


Fount of Information は、新商品、新規取扱メーカーなどの情報をいち早く紹介するコンテンツです。情報発信のスピードを重視しているコンテンツのため、現時点で法規制や取り扱いを確認できていない商品、定価を設定できていない商品があります。ご要望やご照会を受けた商品について、法令整備や在庫の充実を図ります。